rs11545076 — GGH -124T>G

GGH -124T>G — The Folate Retention Gate

Inside every cell, folate is trapped in a useful form: attached to chains of glutamate molecules called polyglutamates¹¹ polyglutamates
Polyglutamate tails: chains of glutamic acid added to folate molecules that anchor them inside cells, making folate more concentrated and metabolically active than the free monoglutamate form that circulates in blood. This trapping is essential — polyglutamated folate is the working form that enzymes in the methylation cycle and nucleotide synthesis actually use. GGH (gamma-glutamyl hydrolase) is the enzyme that cuts these glutamate chains off, converting polyglutamates back to monoglutamates that can leave the cell. The -124T>G promoter variant (rs11545076) increases GGH expression, meaning more of this enzyme is produced — which speeds up the hydrolysis of intracellular folate stores and reduces how much folate the cell can retain.

The Mechanism

The GGH gene sits on chromosome 8q12.3 on the minus (reverse) strand. Its promoter controls how much GGH protein is made. The rs11545076 variant is a T-to-G change at position -124 relative to the translation start (described in papers as coding-strand notation; on the genomic plus strand, this appears as an A-to-C change). Luciferase reporter assays²² Luciferase reporter assays
DeVos et al., 2003 — Identification of SNPs in GGH, Mutat Res 2003 in HepG2 (liver) and MCF-7 (breast) cells showed that the -124G allele significantly increased promoter activity compared to the wild-type -124T allele. Higher GGH activity accelerates the cleavage of polyglutamylated folate to monoglutamylated folate, which is then exported from the cell. The net effect is reduced intracellular folate retention — less folate available for thymidylate synthesis³³ thymidylate synthesis
Thymidylate synthesis: the biochemical pathway that makes thymidine (T), one of the four DNA bases. Folate is the methyl donor in this reaction; folate shortage leads to uracil being misincorporated in place of thymine and methylation reactions.

The Evidence

The clearest human evidence comes from a study of 899 adults⁴⁴ study of 899 adults
DeVos L et al. Associations between SNPs in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil. Am J Clin Nutr, 2008 measuring DNA uracil content — a sensitive marker of intracellular folate sufficiency, since folate shortage causes uracil to be misincorporated into DNA instead of thymidine. Carriers of one C allele (AC genotype; TG in coding notation) had 30% higher DNA uracil levels than AA homozygotes; those with two C alleles (CC; GG in coding notation) had 73% higher DNA uracil (P for trend = 0.022). Crucially, this effect was independent of plasma folate and plasma homocysteine levels — meaning standard blood tests for folate status would appear normal even when intracellular folate is depleted at the cellular level.

In a cohort of 471 Singapore Chinese adults⁵⁵ cohort of 471 Singapore Chinese adults
Oppeneer SJ et al. Genetic variation in FPGS and GGH and plasma homocysteine. Mol Genet Metab, 2012, rs11545076 showed the strongest association with plasma homocysteine of nine GGH variants tested, and was the only variant to survive multiple-comparisons correction (adjusted p=0.001). Interestingly, carriers of the G allele (AC/CC genotypes) had slightly lower — not higher — homocysteine than TT homozygotes (GT: 9.3 nmol/L vs TT: 10.1 nmol/L). This apparent paradox may reflect compensatory redistribution of folate pools: when intracellular retention is reduced, more folate circulates in plasma, potentially supporting remethylation of homocysteine via methionine synthase.

Experimental manipulation of GGH expression in cancer cell lines confirms the downstream methylation effects⁶⁶ confirms the downstream methylation effects
Kim YI et al. γ-Glutamyl hydrolase modulation significantly influences global and gene-specific DNA methylation. Genes Nutr, 2015: GGH overexpression decreased global DNA methylation by 16-22% and reduced DNMT (DNA methyltransferase) activity, while GGH inhibition increased global DNA methylation by 7-15%. These findings establish a direct mechanistic link between GGH activity, intracellular folate retention, and epigenetic regulation.

Practical Actions

The C allele (G in coding notation) increases GGH expression and accelerates intracellular folate depletion. Because plasma folate levels may appear normal despite cellular depletion, standard serum folate tests can miss this effect. Optimizing dietary folate intake from natural sources (leafy greens, legumes, liver) — which arrives as polyglutamates that may be better retained even with elevated GGH — is preferable to relying solely on folic acid supplements. Methylfolate (5-MTHF) supplementation directly provides the active form without requiring intracellular conversion. Monitoring DNA methylation markers or homocysteine as a proxy for folate cycle function may help assess personal folate sufficiency. Individuals carrying the C allele who also have impaired folate conversion (MTHFR C677T) face a compound challenge: reduced conversion capacity plus accelerated intracellular depletion.

Interactions

The most clinically significant interaction is with MTHFR C677T (rs1801133). GGH accelerates cellular folate export while MTHFR C677T impairs conversion of dietary folate to the active methylfolate form. Together, AC or CC at rs11545076 combined with AG or AA at rs1801133 creates a compound reduction in effective intracellular folate: the cell receives less active folate due to impaired conversion, AND retains it less efficiently due to elevated GGH activity. This combination may warrant higher methylfolate doses than either variant alone.

GGH also controls intracellular levels of methotrexate polyglutamates. The related variant rs11545078 (GGH c.452C>T, coding region) reduces GGH activity and paradoxically increases MTX polyglutamate accumulation, causing methotrexate toxicity — the opposite direction from rs11545076. These two variants can co-occur and have opposing effects on methotrexate efficacy. The promoter variant rs3758149 (-401C>T, also listed as C-401T) has similar direction effects to rs11545076 and is in partial linkage disequilibrium.